Skip to content
Events

Details

Illumina will be exhibiting at Long-Read Sequencing Uppsala LRUA 2026 on the 2 - 4 November. 

Come and visit us our booth, where you can meet our expert team to learn about our solutions and services on offer and discuss any requirements you may have. 

We will also be hosting a workshop on 4 November at 13:00 - 13:50 where you will hear from the following speakers:

Genomics redefined: long-range insights for deeper impact​ by Drew Ellershaw, Associate Principal Scientist, Illumina.

TruPath™ Whole Genome Sequencing (tpWGS) - an alternative for High-Resolution Cytogenetic Analysis​ by Sjoerd Holwerda, Laboratory Specialist in Clinical Genetics, UMC Utrecht.

Direct haplotyping of parents enables untargeted non-invasive prenatal testing by Joanna von Berg, Senior Postdoc, UMC Utrecht.

To access more information about this event, visit the website. 

 

 

M-EMEA-00892

Date & Time
2 Nov 2026 – 4 Nov 2026
Location
Uppsala
Sweden
Europe
Topic
Genetic & rare diseases
Visit Website

Related Events

Oct 20
Voices of the Next Generation of Leaders in Genomic Medicine Research
20 Oct 2026
By featuring early career investigators, the Voices of the Next Generation of Leaders in Genomic Medicine Research symposium will showcase the work of the next generation of leaders in genomic medicine research.
View Event
Oct 21
Expanding the genomic toolkit with streamlined long-range and epigenetic insights
21 Oct 2026
Explore streamlined long-range and epigenetic insights in this on-demand ASHG 2026 Industry Education session.
View Event
For Research Use Only

Not for use in diagnostic procedures.

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.